Pediatrics Practice Valuation Ranges
By Published On: April 14, 2026
Expert Analysis

Pediatrics Practice Valuation Ranges: 2026

Pediatric practices sit at the intersection of essential care, demographic tailwinds, and reimbursement complexity. As a core primary care service for children, demand remains relatively non-discretionary, while birth trends, population shifts, and Medicaid exposure create both volume opportunity and payer-mix risk that directly influence long-term valuation stability.

In 2026, valuation expectations reflect a healthcare market that has stabilized from post-pandemic volatility while remaining highly selective. Private equity (PE) activity has normalized, strategic buyers remain disciplined, and platform-quality assets continue to command premiums.

This page summarizes current valuation ranges for pediatric practices using independent third-party research and industry reports from 2025–2026. All ranges are presented for educational purposes only and reflect market observations, not guarantees of outcome.

 

The 2026 Healthcare Services Backdrop

According to the PitchBook Q4 2025 Healthcare Services Report, healthcare services deal activity showed mixed signals in 2025. Total deal count increased approximately 9.6% year-over-year to an estimated 747 transactions, indicating continued underlying demand for healthcare assets. However, fourth-quarter activity declined roughly 15% compared to the prior year, reflecting temporary market friction as investors awaited regulatory clarity and adjusted to evolving physician practice management (PPM) oversight.

PitchBook also reports that exit activity increased meaningfully, with exit count rising 17.1% and exit value up 14.1%, signaling improving liquidity conditions and setting the stage for renewed transaction momentum. Within physician practice management, activity declined approximately 18% in 2025, with softness concentrated in dental, vision, and dermatology. This was partially offset by continued strength in specialties such as oncology and musculoskeletal care, highlighting a growing bifurcation in investor demand across healthcare subsectors.

Additionally, a significant portion of private equity-backed healthcare services assets are now in extended hold periods, with many investments held for five to seven years or longer. This growing inventory of aged assets is expected to contribute to increased transaction activity as sponsors seek liquidity.

From a public markets perspective, PitchBook reports that healthcare services valuation multiples remain near long-term averages of approximately 10× EV/TTM EBITDA. Provider multiples experienced modest compression in the second half of 2025 due to anticipated reimbursement pressures, though overall performance remained supported by strong utilization trends.

Looking ahead, PitchBook notes that strategic demand for healthcare services assets is expected to strengthen in 2026, particularly among health systems pursuing ambulatory expansion and physician practice acquisitions. The report also highlights the growing role of AI in improving operational efficiency and supporting returns, reinforcing a constructive—though increasingly selective—valuation environment.

 

Where Pediatrics Fits in Healthcare Valuation Benchmarks

While pediatrics is not always reported as a standalone category, it typically falls under primary care or multispecialty physician practice benchmarks.

According to VMGHealth, primary care and multispecialty physician platforms commonly achieve:

Platform transactions: 8×–12× EBITDA

Add-on transactions: 3×–6× EBITDA

Typical revenue multiples: ~0.8×–1.6× revenue

 

Similarly, they report:

Medical practices (multi-specialty):

$1–3M EBITDA: 5.6×

$3–5M EBITDA: 7.1×

$5–10M EBITDA: 8.8×

 

According to PitchBook, public healthcare services valuation multiples have normalized near long-term averages of approximately 10× EV/TTM EBITDA, reflecting a stabilization in valuation levels rather than a structural decline.

Source: works cited combined with guidance from internal bankers, based generally on knowledge and experience. Actual pricing varies with each transaction based on many factors. Intended for educational purposes only and not a guarantee of any outcome.

 

What This Means for Pediatrics

For most independent pediatric practices:

Smaller owner-operated practices ($1–3M EBITDA) likely trade in the 5×–8× EBITDA range, depending on growth, payer mix, and structure.

Scaled pediatric platforms ($3M+ EBITDA, multi-location) may reach 8×–10×+ EBITDA, particularly if positioned as regional or multi-state consolidation vehicles.

Revenue multiples typically cluster between 1.0×–1.5×, though margin profile can materially shift this range.

 

2026 Pediatric Practice Valuation Ranges

Below is a consolidated 2026 reference range for pediatric practices, based on physician practice and healthcare services benchmarks from PitchBook and healthcare M&A data.

Practice Type EBITDA Range Typical 2026 EV/EBITDA Revenue Multiple Range
Solo / Small Practice <$1M 4.5×–6.5× 0.8×–1.2×
Lower Mid-Market $1–3M 5.5×–7.5× 1.0×–1.4×
Regional Platform $3–7M 7×–9× 1.2×–1.6×
Multi-State Platform $7M+ 8×–11×+ 1.3×–1.8×

These ranges align with reported multispecialty and primary care valuation bands in 2025. Actual pricing depends heavily on quality metrics, structure, and buyer competition.

Source: works cited combined with guidance from internal bankers, based generally on knowledge and experience. Actual pricing varies with each transaction based on many factors. Intended for educational purposes only and not a guarantee of any outcome.

 

Key Drivers of Pediatric Practice Valuation in 2026

1. Scale and Infrastructure

Mid-market dominance remains a consistent theme. Providers in the $3–10M EBITDA range command the strongest pricing leverage, aligning with PE’s preferred platform size.

For pediatrics, this means:

Multi-location density

A deep provider bench, utilizing physicians and midlevels

Centralized billing and RCM

Professional management

Standardized clinical protocols

 

Scaled infrastructure signals platform potential rather than pure income replacement.

2. Payer Mix and Reimbursement Stability

Pitchbook’s 2026 Outlook highlights continued payer mix challenges due to potential Medicaid tightening and ACA premium tax credit dynamics.

Since pediatric practices are often heavily Medicaid-exposed:

High Medicaid concentration may compress multiples.

Diversified commercial payer mix supports premium outcomes.

Participation in value-based care models may enhance strategic appeal.

 

Primary care benchmarks explicitly note that value-based care participation can lift valuation multiples.

3. Demographic Tailwinds

The 2026 Outlook emphasizes utilization growth driven by demographic trends, particularly as patient acuity rises across healthcare segments.

For pediatrics:

Population growth in high-birth regions

Chronic pediatric condition management

Integration with specialty pediatric services (behavioral health, developmental therapy)

 

Demographically advantaged markets tend to trade at the higher end of valuation bands. Examples include high-growth Sunbelt metros such as Dallas–Fort Worth, Phoenix, and Tampa, where above-average population growth and in-migration of young families support sustained pediatric demand, as well as affluent suburban corridors with strong commercial payer mix and higher household income levels that enhance reimbursement stability.

 

Public Market Context and Its Influence

According to PitchBook, public healthcare services valuation multiples for hospitals and providers remain near long-term averages of approximately 10× EV/TTM EBITDA. However, provider multiples experienced modest compression in the second half of 2025 due to anticipated reimbursement pressures, while overall performance remained supported by strong utilization trends.

Public comps influence private market pricing by:

Setting return thresholds for strategic acquirers

Anchoring sponsor underwriting models

Determining arbitrage opportunities between private and public valuations

 

When public valuations remain stable, private market compression is typically limited to asset-specific weaknesses rather than systemic collapse.

 

2026 Outlook: Acceleration with Selectivity

According to PitchBook’s Q4 2025 Healthcare Services Report, healthcare services activity is expected to strengthen in 2026, supported by improving liquidity conditions and increased strategic buyer participation. Health systems are expected to re-engage in physician practice acquisitions and ambulatory expansion initiatives, while private equity sponsors work through a growing backlog of exit-ready assets.

PitchBook also highlights the increasing role of AI in healthcare services, particularly in revenue cycle management and clinical workflow optimization, which is expected to enhance operational efficiency and support long-term valuation stability.

However, the rebound is expected to favor:

Scalable, defensible models

Infrastructure-ready platforms

Compliance-forward operators

 

For pediatrics, that means:

Clean financial reporting

Professional management teams

Scalable care delivery

Strong clinical governance

 

Lower-quality, highly owner-dependent practices without growth infrastructure are likely to trade at discounts to benchmark ranges.

 

Summary: 2026 Pediatric Practice Valuation Expectations

Based on 2025–2026 healthcare services data:

Independent pediatric practices likely trade between 5×–8× EBITDA.

Scaled regional pediatric platforms may achieve 8×–10×+ EBITDA.

Revenue multiples generally fall between 1.0× and 1.5×, depending on margins.

Platform positioning, payer diversification, and infrastructure maturity materially impact outcomes.

Healthcare services valuation has normalized rather than collapsed, with public medians around 12.4× TEV/EBITDA in mid-2025 and provider valuations near long-term averages.

 

As 2026 unfolds, pediatric practices with scale, operational rigor, and diversified payer mix are positioned to trade toward the upper end of physician services benchmarks.

Note: This article is intended for educational purposes only. Valuations vary widely based on market conditions, buyer demand, and company-specific factors. Always conduct independent diligence when evaluating strategic alternatives.

 

Requesting a Copy of This Report

FOCUS Investment Banking specializes in maximizing transaction value for healthcare practice owners through our proven quarterback approach to M&A advisory.

If you’d like to learn more about our healthcare investment banking services, you can reach out here.

 

Sources:

PitchBook Q4 2025 Healthcare Services Report

PitchBook 2026 Healthcare Outlook

VMG Health 2025 M&A Report

Scope Research Healthcare M&A Valuation Review (2025)

Eric Yetter is an investment banker focused on healthcare provider services. Yetter has completed a variety of healthcare transactions, many with private equity firms and PE-backed companies. His past clients include leading physician and dental groups, behavioral health companies, healthcare facilities, and institutional healthcare investors.